TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10457838
log Bayes Factor = <0.0001
Chromosome 6   position 149,357,547  (GRCh37) Explore rs10457838 on Ensembl!
Variant rs10457838 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.980 0.020
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.981 0.019
T43.2 Other and unspecified antidepressants
0.000 0.982 0.018
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.984 0.016
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.016 0.984 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.985 0.015
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.986 0.014
M06.0 Seronegative rheumatoid arthritis
0.014 0.986 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.986 0.014
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.986 0.014
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.986 0.014
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness
0.013 0.987 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.013 0.987 0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.012 0.988 0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.012 0.988 0.000
T43.6 Psychostimulants with abuse potential
0.000 0.989 0.011
Y40.0 Penicillins
0.010 0.990 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.010 0.990 0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.010 0.990 0.000
M06.04 Seronegative rheumatoid arthritis (Hand)
0.010 0.990 0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.010 0.990 0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.010 0.990 0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.010 0.990 0.000
Z91.6 Personal history of other physical trauma
0.010 0.990 0.000
M25.54 Pain in joint (Hand)
0.000 0.991 0.009
G63.2 Diabetic polyneuropathy
0.009 0.991 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.991 0.009
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.991 0.009
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.991 0.009
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.991 0.009
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.991 0.009
H47.3 Other disorders of optic disk
0.008 0.992 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.992 0.008
T45.0 Antiallergic and antiemetic drugs
0.000 0.992 0.008
H47 Other disorders of optic [2nd] nerve and visual pathways
0.008 0.992 0.000
T42.1 Iminostilbenes
0.000 0.992 0.008
H47.1 Papilloedema, unspecified
0.008 0.992 0.000
H47.2 Optic atrophy
0.008 0.992 0.000
T45.5 Anticoagulants
0.000 0.992 0.008
V18.0 Driver injured in nontraffic accident
0.008 0.992 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.992 0.008
F40.2 Specific (isolated) phobias
0.000 0.992 0.008
T42.0 Hydantoin derivatives
0.000 0.993 0.007
V18 Pedal cyclist injured in noncollision transport accident
0.007 0.993 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.993 0.007
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.993 0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.993 0.007
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.993 0.007
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.993 0.007
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.993 0.007
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.993 0.007
T42.3 Barbiturates
0.000 0.993 0.007
T42.2 Succinimides and oxazolidinediones
0.000 0.993 0.007
T36 Poisoning by systemic antibiotics
0.000 0.993 0.007
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.993 0.006
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.993 0.006
T46.7 Peripheral vasodilators
0.000 0.993 0.006
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.993 0.006
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.993 0.006
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.994 0.006
T45.8 Other primarily systemic and haematological agents
0.000 0.994 0.006
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.994 0.006
T45.6 Fibrinolysis-affecting drugs
0.000 0.994 0.006
T45.4 Iron and its compounds
0.000 0.994 0.006
T45.3 Enzymes, not elsewhere classified
0.000 0.994 0.006
V18.3 Person injured while boarding or alighting
0.006 0.994 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.994 0.006
H47.7 Disorder of visual pathways, unspecified
0.006 0.994 0.000
H47.6 Disorders of visual cortex
0.006 0.994 0.000
H47.5 Disorders of other visual pathways
0.006 0.994 0.000
H47.4 Disorders of optic chiasm
0.006 0.994 0.000
V18.1 Passenger injured in nontraffic accident
0.006 0.994 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.994 0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.994 0.006
T46.1 Calcium-channel blockers
0.000 0.994 0.006
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.006 0.994 0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident
0.006 0.994 0.000
M06 Other rheumatoid arthritis
0.006 0.994 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.994 0.006
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.994 0.006
M25.52 Pain in joint (Upper arm)
0.006 0.994 0.000
H47.0 Disorders of optic nerve, not elsewhere classified
0.006 0.994 0.000
V18.9 Unspecified pedal cyclist injured in traffic accident
0.005 0.995 0.000
V18.4 Driver injured in traffic accident
0.005 0.995 0.000
V18.5 Passenger injured in traffic accident
0.005 0.995 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.995 0.005
Y40 Systemic antibiotics
0.005 0.995 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.995 0.005
T37.5 Antiviral drugs
0.000 0.995 0.005
T37.4 Anthelminthics
0.000 0.995 0.005
T37.3 Other antiprotozoal drugs
0.000 0.995 0.005
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.995 0.005
T37.1 Antimycobacterial drugs
0.000 0.995 0.005
T37.0 Sulphonamides
0.000 0.995 0.005
M06.8 Other specified rheumatoid arthritis
0.005 0.995 0.000
T41.5 Therapeutic gases
0.000 0.995 0.005
T41.4 Anaesthetic, unspecified
0.000 0.995 0.005
T41.3 Local anaesthetics
0.000 0.995 0.005
T41.2 Other and unspecified general anaesthetics
0.000 0.995 0.005
T41.1 Intravenous anaesthetics
0.000 0.995 0.005
T41.0 Inhaled anaesthetics
0.000 0.995 0.005
T49.9 Topical agent, unspecified
0.000 0.995 0.005
T49.8 Other topical agents
0.000 0.995 0.005
T49.7 Dental drugs, topically applied
0.000 0.995 0.005
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.995 0.005
T49.5 Ophthalmological drugs and preparations
0.000 0.995 0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.995 0.005
T49.3 Emollients, demulcents and protectants
0.000 0.995 0.005
T49.2 Local astringents and local detergents
0.000 0.995 0.005
T49.1 Antipruritics
0.000 0.995 0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.995 0.005
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.995 0.005
T36.9 Systemic antibiotic, unspecified
0.000 0.995 0.005
T36.8 Other systemic antibiotics
0.000 0.995 0.005
T36.7 Antifungal antibiotics, systemically used
0.000 0.995 0.005
T36.6 Rifamycins
0.000 0.995 0.005
T36.5 Aminoglycosides
0.000 0.995 0.005
T36.4 Tetracyclines
0.000 0.995 0.005
T36.3 Macrolides
0.000 0.995 0.005
T36.2 Chloramphenicol group
0.000 0.995 0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.995 0.005
T45.2 Vitamins, not elsewhere classified
0.000 0.995 0.005
T36.0 Penicillins
0.000 0.995 0.005
T40.2 Other opioids
0.000 0.995 0.005
S69.9 Unspecified injury of wrist and hand
0.005 0.995 0.000
M06.3 Rheumatoid nodule
0.005 0.995 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.995 0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.995 0.004
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.995 0.004
T47.7 Emetics
0.000 0.995 0.004
T47.6 Antidiarrhoeal drugs
0.000 0.995 0.004
T47.5 Digestants
0.000 0.995 0.004
T47.3 Saline and osmotic laxatives
0.000 0.995 0.004
T47.2 Stimulant laxatives
0.000 0.995 0.004
T47.0 Histamine H(2)-receptor antagonists
0.000 0.995 0.004
Y52 Agents primarily affecting the cardiovascular system
0.005 0.995 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.995 0.004
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.005 0.995 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.004 0.996 0.000
T47.4 Other laxatives
0.000 0.996 0.004
M06.2 Rheumatoid bursitis
0.004 0.996 0.000
M06.1 Adult-onset Still's disease
0.004 0.996 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.996 0.004
T40.8 Lysergide [LSD]
0.000 0.996 0.004
T40.7 Cannabis (derivatives)
0.000 0.996 0.004
T40.3 Methadone
0.000 0.996 0.004
T40.1 Heroin
0.000 0.996 0.004
T40.0 Opium
0.000 0.996 0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.996 0.004
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.996 0.004
T48.4 Expectorants
0.000 0.996 0.004
T48.3 Antitussives
0.000 0.996 0.004
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.996 0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
T48.0 Oxytocic drugs
0.000 0.996 0.004
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.996 0.004
G63 Polyneuropathy in diseases classified elsewhere
0.004 0.996 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.004 0.996 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.004 0.996 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.004 0.996 0.000
D89.1 Cryoglobulinaemia
0.004 0.996 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.996 0.004
V18.49 Pedal cyclist injured in noncollision transport accident; driver injured in traffic accident ; during unspecified activity
0.004 0.996 0.000
V18.99 Pedal cyclist injured in noncollision transport accident; unspecified pedal cyclist injured in traffic accident; during unspecified activity
0.004 0.996 0.000
S92.00 Fracture of calcaneus (closed)
0.004 0.996 0.000
D89.2 Hypergammaglobulinaemia, unspecified
0.004 0.996 0.000
V10-V19 Pedal cyclist injured in transport accident
0.004 0.996 0.000
Y40.4 Tetracyclines
0.004 0.996 0.000
Y52.7 Peripheral vasodilators
0.004 0.996 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.004 0.996 0.000
T40.5 Cocaine
0.000 0.996 0.004
Y40.7 Antifungal antibiotics, systemically used
0.004 0.996 0.000
Y52.1 Calcium-channel blockers
0.004 0.996 0.000
Y40.6 Rifamycins
0.004 0.996 0.000
Y40.2 Chloramphenicol group
0.004 0.996 0.000
M06.88 Other specified rheumatoid arthritis (Other)
0.004 0.996 0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.004 0.996 0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.004 0.996 0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.004 0.996 0.000
M06.84 Other specified rheumatoid arthritis (Hand)
0.004 0.996 0.000
M06.83 Other specified rheumatoid arthritis (Forearm)
0.004 0.996 0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.004 0.996 0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.004 0.996 0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.004 0.996 0.000
T40.6 Other and unspecified narcotics
0.000 0.996 0.004
M43.17 Spondylolisthesis (Lumbosacral region)
0.004 0.996 0.000
Y40.5 Aminoglycosides
0.004 0.996 0.000
M06.32 Rheumatoid nodule (Upper arm)
0.004 0.996 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.996 0.004
T38.7 Androgens and anabolic congeners
0.000 0.996 0.004
T38.5 Other oestrogens and progestogens
0.000 0.996 0.004
T38.4 Oral contraceptives
0.000 0.996 0.004
T38.2 Antithyroid drugs
0.000 0.996 0.004
T38.0 Glucocorticoids and synthetic analogues
0.000 0.996 0.004
Y40.3 Macrolides
0.004 0.996 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.004 0.996 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.004 0.996 0.000
T42.4 Benzodiazepines
0.000 0.996 0.004
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.004 0.996 0.000
Z63.4 Disappearance and death of family member
0.000 0.996 0.004
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.996 0.003
M06.39 Rheumatoid nodule (Site unspecified)
0.004 0.996 0.000
M06.38 Rheumatoid nodule (Other)
0.004 0.996 0.000
M06.36 Rheumatoid nodule (Lower leg)
0.004 0.996 0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.004 0.996 0.000
M06.33 Rheumatoid nodule (Forearm)
0.004 0.996 0.000
M06.31 Rheumatoid nodule (Shoulder region)
0.004 0.996 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.996 0.003
M06.34 Rheumatoid nodule (Hand)
0.004 0.996 0.000
T50.7 Analeptics and opioid receptor antagonists
0.000 0.996 0.003
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.996 0.003
T50.5 Appetite depressants
0.000 0.996 0.003
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.996 0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.996 0.003
T50.1 Loop [high-ceiling] diuretics
0.000 0.996 0.003
T50.0 Mineralocorticoids and their antagonists
0.000 0.996 0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.004 0.996 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.004 0.996 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.004 0.996 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.004 0.996 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.996 0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.996 0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.996 0.003
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.996 0.003
T44.0 Anticholinesterase agents
0.000 0.996 0.003
T50.8 Diagnostic agents
0.000 0.996 0.003
K43.9 Ventral hernia without obstruction or gangrene
0.004 0.996 0.000
M06.4 Inflammatory polyarthropathy
0.003 0.996 0.000
T48.5 Anti-common-cold drugs
0.001 0.996 0.003
Y53 Agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
T40.4 Other synthetic narcotics
0.000 0.996 0.003
Y40.8 Other systemic antibiotics
0.003 0.996 0.000
S52.10 Fracture of upper end of radius (closed)
0.004 0.996 0.000
Y58 Bacterial vaccines
0.003 0.996 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.003 0.996 0.000
D89.0 Polyclonal hypergammaglobulinaemia
0.003 0.997 0.000
Y95 Nosocomial condition
0.003 0.997 0.000
M06.19 Adult-onset Still's disease (Site unspecified)
0.003 0.997 0.000
M06.18 Adult-onset Still's disease (Other)
0.003 0.997 0.000
M06.17 Adult-onset Still's disease (Ankle and foot)
0.003 0.997 0.000
M06.16 Adult-onset Still's disease (Lower leg)
0.003 0.997 0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.003 0.997 0.000
M06.14 Adult-onset Still's disease (Hand)
0.003 0.997 0.000
M06.13 Adult-onset Still's disease (Forearm)
0.003 0.997 0.000
M06.12 Adult-onset Still's disease (Upper arm)
0.003 0.997 0.000
M06.11 Adult-onset Still's disease (Shoulder region)
0.003 0.997 0.000
M06.10 Adult-onset Still's disease (Multiple sites)
0.003 0.997 0.000
M06.29 Rheumatoid bursitis (Site unspecified)
0.003 0.997 0.000
M06.28 Rheumatoid bursitis (Other)
0.003 0.997 0.000
M06.27 Rheumatoid bursitis (Ankle and foot)
0.003 0.997 0.000
M06.26 Rheumatoid bursitis (Lower leg)
0.003 0.997 0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.003 0.997 0.000
M06.24 Rheumatoid bursitis (Hand)
0.003 0.997 0.000
M06.23 Rheumatoid bursitis (Forearm)
0.003 0.997 0.000
M06.22 Rheumatoid bursitis (Upper arm)
0.003 0.997 0.000
M06.21 Rheumatoid bursitis (Shoulder region)
0.003 0.997 0.000
M06.20 Rheumatoid bursitis (Multiple sites)
0.003 0.997 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
G63.8 Polyneuropathy in other diseases classified elsewhere
0.003 0.997 0.000
G63.6 Polyneuropathy in other musculoskeletal disorders
0.003 0.997 0.000
G63.5 Polyneuropathy in systemic connective tissue disorders
0.003 0.997 0.000
G63.4 Polyneuropathy in nutritional deficiency
0.003 0.997 0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases
0.003 0.997 0.000
G63.1 Polyneuropathy in neoplastic disease
0.003 0.997 0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
R41 Other symptoms and signs involving cognitive functions and awareness
0.003 0.997 0.000
M05-M14 Inflammatory polyarthropathies
0.003 0.997 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.003 0.997 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.003 0.997 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.003 0.997 0.000
H46-H48 Disorders of optic nerve and visual pathways
0.003 0.997 0.000
Y58.0 BCG vaccine
0.003 0.997 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.003 0.997 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.997 0.003
Y49.5 Other antipsychotics and neuroleptics
0.003 0.997 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.003 0.997 0.000
Y54.5 Other diuretics
0.003 0.997 0.000
V19 Pedal cyclist injured in other and unspecified transport accidents
0.003 0.997 0.000
M11 Other crystal arthropathies
0.003 0.997 0.000
K43.0 Ventral hernia with obstruction, without gangrene
0.003 0.997 0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle
0.003 0.997 0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle
0.003 0.997 0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus
0.003 0.997 0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van
0.003 0.997 0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle
0.003 0.997 0.000
V10 Pedal cyclist injured in collision with pedestrian or animal
0.003 0.997 0.000
D89.9 Disorder involving the immune mechanism, unspecified
0.003 0.997 0.000
M10.0 Idiopathic gout
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.003 0.997 0.000
M10.07 Idiopathic gout (Ankle and foot)
0.003 0.997 0.000
R41.2 Retrograde amnesia
0.003 0.997 0.000
D89.3 Immune reconstitution syndrome
0.003 0.997 0.000
M06.37 Rheumatoid nodule (Ankle and foot)
0.003 0.997 0.000
M10 Gout
0.003 0.997 0.000
M45.X2 Ankylosing spondylitis (Cervical region)
0.003 0.997 0.000
Y46.4 Iminostilbenes
0.003 0.997 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.003 0.997 0.000
V28 Motorcycle rider injured in noncollision transport accident
0.003 0.997 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.003 0.997 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.003 0.997 0.000
V20-V29 Motorcycle rider injured in transport accident
0.003 0.997 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.997 0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.003 0.997 0.000
Y54.4 Loop [high-ceiling] diuretics
0.003 0.997 0.000
M11.2 Other chondrocalcinosis
0.003 0.997 0.000
Y56.9 Topical agent, unspecified
0.003 0.997 0.000
Y56.8 Other topical agents
0.003 0.997 0.000
Y56.7 Dental drugs, topically applied
0.003 0.997 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.003 0.997 0.000
Y56.5 Ophthalmological drugs and preparations
0.003 0.997 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.003 0.997 0.000
Y56.3 Emollients, demulcents and protectants
0.003 0.997 0.000
Y56.2 Local astringents and local detergents
0.003 0.997 0.000
Y56.1 Antipruritics
0.003 0.997 0.000
V27.4 Driver injured in traffic accident
0.003 0.997 0.000
M48.02 Spinal stenosis (Cervical region)
0.003 0.997 0.000
M14 Arthropathies in other diseases classified elsewhere
0.003 0.997 0.000
V27 Motorcycle rider injured in collision with fixed or stationary object
0.003 0.997 0.000
M06.46 Inflammatory polyarthropathy (Lower leg)
0.003 0.997 0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.003 0.997 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.003 0.997 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.997 0.000
M12 Other specific arthropathies
0.003 0.997 0.000
Chapter XX External causes of morbidity and mortality
0.003 0.997 0.000
I45.1 Other and unspecified right bundle-branch block
0.000 0.997 0.003
Y54.9 Mineral salts, not elsewhere classified
0.003 0.997 0.000
Y54.7 Agents affecting calcification
0.003 0.997 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.003 0.997 0.000
Y54.0 Mineralocorticoids
0.003 0.997 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.003 0.997 0.000
M08 Juvenile arthritis
0.003 0.997 0.000
V28.3 Person injured while boarding or alighting
0.003 0.997 0.000
M45 Ankylosing spondylitis
0.003 0.997 0.000
K43 Ventral hernia
0.003 0.997 0.000
M06.48 Inflammatory polyarthropathy (Other)
0.003 0.997 0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.003 0.997 0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.003 0.997 0.000
M06.44 Inflammatory polyarthropathy (Hand)
0.003 0.997 0.000
M06.43 Inflammatory polyarthropathy (Forearm)
0.003 0.997 0.000
M06.42 Inflammatory polyarthropathy (Upper arm)
0.003 0.997 0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.003 0.997 0.000
M19.97 Arthrosis, unspecified (Ankle and foot)
0.003 0.997 0.000
D28.0 Vulva
0.003 0.997 0.000
M11.9 Crystal arthropathy, unspecified
0.003 0.997 0.000
R41.1 Anterograde amnesia
0.003 0.997 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.003 0.997 0.000
Y53.7 Emetics
0.003 0.997 0.000
Y53.6 Antidiarrhoeal drugs
0.003 0.997 0.000
Y53.5 Digestants
0.003 0.997 0.000
Y53.3 Saline and osmotic laxatives
0.003 0.997 0.000
Y53.2 Stimulant laxatives
0.003 0.997 0.000
Y53.0 Histamine H2-receptor antagonists
0.003 0.997 0.000
Y59 Other and unspecified vaccines and biological substances
0.003 0.997 0.000
M11.26 Other chondrocalcinosis (Lower leg)
0.003 0.997 0.000
S69 Other and unspecified injuries of wrist and hand
0.003 0.997 0.000
V11 Pedal cyclist injured in collision with other pedal cycle
0.003 0.997 0.000
K55.9 Vascular disorder of intestine, unspecified
0.003 0.997 0.000
Y58.9 Other and unspecified bacterial vaccines
0.003 0.997 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.003 0.997 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.003 0.997 0.000
Y58.5 Diphtheria vaccine
0.003 0.997 0.000
Y58.4 Tetanus vaccine
0.003 0.997 0.000
Y58.3 Plague vaccine
0.003 0.997 0.000
Y58.2 Cholera vaccine
0.003 0.997 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.003 0.997 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
V19.8 Pedal cyclist [any] injured in other specified transport accidents
0.003 0.997 0.000
X00-X09 Exposure to smoke, fire and flames
0.003 0.997 0.000
M10.04 Idiopathic gout (Hand)
0.003 0.997 0.000
I77.8 Other specified disorders of arteries and arterioles
0.003 0.997 0.000
M14.8 Arthropathies in other specified diseases classified elsewhere
0.003 0.997 0.000
Y54.8 Agents affecting uric acid metabolism
0.003 0.997 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.003 0.997 0.000
K55.2 Angiodysplasia of colon
0.003 0.997 0.000
Y49.9 Psychotropic drug, unspecified
0.003 0.997 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
Y49.7 Psychostimulants with abuse potential
0.003 0.997 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.003 0.997 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.003 0.997 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.003 0.997 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.003 0.997 0.000
Y46.7 Anti-Parkinsonism drugs
0.003 0.997 0.000
Y49.2 Other and unspecified antidepressants
0.003 0.997 0.000
M09 Juvenile arthritis in diseases classified elsewhere
0.003 0.997 0.000
M05 Seropositive rheumatoid arthritis
0.003 0.997 0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere
0.003 0.997 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.002 0.997 0.000
V28.2 Unspecified motorcycle rider injured in nontraffic accident
0.003 0.997 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.003 0.997 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.997 0.000
Y55.5 Anticommon cold drugs
0.002 0.997 0.000
Y55.4 Expectorants
0.002 0.997 0.000
Y55.3 Antitussives
0.002 0.997 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.002 0.997 0.000
Y55.0 Oxytocic drugs
0.002 0.997 0.000
Y46.6 Other and unspecified antiepileptics
0.003 0.997 0.000
Y53.4 Other laxatives
0.003 0.997 0.000
Y44 Agents primarily affecting blood constituents
0.003 0.997 0.000
Y10-Y34 Event of undetermined intent
0.003 0.997 0.000
M45.X6 Ankylosing spondylitis (Lumbar region)
0.003 0.997 0.000
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.997 0.000
Y46.8 Antispasticity drugs
0.002 0.997 0.000
Y46.5 Valproic acid
0.002 0.997 0.000
Y46.3 Deoxybarbiturates
0.002 0.997 0.000
Y46.1 Oxazolidinediones
0.002 0.997 0.000
Y46.0 Succinimides
0.002 0.997 0.000
V98-V99 Other and unspecified transport accidents
0.003 0.997 0.000
M10.96 Gout, unspecified (Lower leg)
0.003 0.997 0.000
M11.8 Other specified crystal arthropathies
0.002 0.997 0.000
M11.1 Familial chondrocalcinosis
0.002 0.997 0.000
M11.0 Hydroxyapatite deposition disease
0.002 0.997 0.000
M12.3 Palindromic rheumatism
0.002 0.997 0.000
V19.9 Pedal cyclist [any] injured in unspecified traffic accident
0.002 0.997 0.000
V19.6 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.997 0.000
V19.2 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident
0.002 0.997 0.000
V19.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.997 0.000
V19.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident
0.002 0.997 0.000
V19.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident
0.002 0.997 0.000
M10.09 Idiopathic gout (Site unspecified)
0.002 0.997 0.000
M10.08 Idiopathic gout (Other)
0.002 0.997 0.000
M10.06 Idiopathic gout (Lower leg)
0.002 0.997 0.000
M10.05 Idiopathic gout (Pelvic region and thigh)
0.002 0.997 0.000
M10.03 Idiopathic gout (Forearm)
0.002 0.997 0.000
M10.02 Idiopathic gout (Upper arm)
0.002 0.997 0.000
M10.01 Idiopathic gout (Shoulder region)
0.002 0.997 0.000
M10.00 Idiopathic gout (Multiple sites)
0.002 0.997 0.000
V10.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.997 0.000
V10.5 Passenger injured in traffic accident
0.002 0.997 0.000
V10.4 Driver injured in traffic accident
0.002 0.997 0.000
V10.3 Person injured while boarding or alighting
0.002 0.997 0.000
V10.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.997 0.000
V10.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V10.0 Driver injured in nontraffic accident
0.002 0.997 0.000
V12.4 Driver injured in traffic accident
0.002 0.997 0.000
V12.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.997 0.000
V12.5 Passenger injured in traffic accident
0.002 0.997 0.000
V12.3 Person injured while boarding or alighting
0.002 0.997 0.000
V12.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.997 0.000
V12.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V12.0 Driver injured in nontraffic accident
0.002 0.997 0.000
V13.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.997 0.000
V13.4 Driver injured in traffic accident
0.002 0.997 0.000
V13.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.997 0.000
V13.5 Passenger injured in traffic accident
0.002 0.997 0.000
V13.3 Person injured while boarding or alighting
0.002 0.997 0.000
V13.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V13.0 Driver injured in nontraffic accident
0.002 0.997 0.000
V14.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.997 0.000
V14.5 Passenger injured in traffic accident
0.002 0.997 0.000
V14.4 Driver injured in traffic accident
0.002 0.997 0.000
V14.3 Person injured while boarding or alighting
0.002 0.997 0.000
V14.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.997 0.000
V14.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V14.0 Driver injured in nontraffic accident
0.002 0.997 0.000
V15.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.997 0.000
V15.5 Passenger injured in traffic accident
0.002 0.997 0.000
V15.4 Driver injured in traffic accident
0.002 0.997 0.000
V15.3 Person injured while boarding or alighting
0.002 0.997 0.000
V15.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.997 0.000
V15.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V15.0 Driver injured in nontraffic accident
0.002 0.997 0.000
V16.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.997 0.000
V16.5 Passenger injured in traffic accident
0.002 0.997 0.000
V16.4 Driver injured in traffic accident
0.002 0.997 0.000
V16.3 Person injured while boarding or alighting
0.002 0.997 0.000
V16.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.997 0.000
V16.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V16.0 Driver injured in nontraffic accident
0.002 0.997 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.002 0.997 0.000
Y48 Anaesthetics and therapeutic gases
0.002 0.997 0.000
M11.96 Crystal arthropathy, unspecified (Lower leg)
0.002 0.997 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.997 0.002
Y65.8 Other specified misadventures during surgical and medical care
0.003 0.997 0.000
I84.7 Unspecified thrombosed haemorrhoids
0.000 0.997 0.003
M08.0 Juvenile rheumatoid arthritis
0.002 0.997 0.000
O66.0 Obstructed labour due to shoulder dystocia
0.003 0.997 0.000
S69.7 Multiple injuries of wrist and hand
0.002 0.997 0.000
V28.9 Unspecified motorcycle rider injured in traffic accident
0.002 0.997 0.000
H46 Optic neuritis
0.002 0.997 0.000
M10.4 Other secondary gout
0.002 0.997 0.000
M10.3 Gout due to impairment of renal function
0.002 0.997 0.000
M10.2 Drug-induced gout
0.002 0.997 0.000
M10.1 Lead-induced gout
0.002 0.997 0.000
M14.2 Diabetic arthropathy
0.002 0.997 0.000
O41.8 Other specified disorders of amniotic fluid and membranes
0.003 0.997 0.000
X00 Exposure to uncontrolled fire in building or structure
0.002 0.997 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.003 0.997 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
0.003 0.997 0.000
R20.8 Other and unspecified disturbances of skin sensation
0.000 0.997 0.003
X50-X57 Overexertion, travel and privation
0.002 0.997 0.000
V01-V09 Pedestrian injured in transport accident
0.002 0.997 0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.002 0.997 0.000
Y65 Other misadventures during surgical and medical care
0.002 0.997 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.002 0.997 0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)
0.002 0.997 0.000
S69.8 Other specified injuries of wrist and hand
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.